These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25659981)

  • 21. Flibanserin.
    Vallejos X; Wu C
    J Pharm Pract; 2017 Apr; 30(2):256-260. PubMed ID: 26873507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flibanserin - the female Viagra?
    Shapiro D; Stevens D; Stahl SM
    Int J Psychiatry Clin Pract; 2017 Nov; 21(4):259-265. PubMed ID: 28434386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flibanserin treatment increases appetitive sexual motivation in the female rat.
    Gelez H; Greggain-Mohr J; Pfaus JG; Allers KA; Giuliano F
    J Sex Med; 2013 May; 10(5):1231-9. PubMed ID: 23421417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flibanserin and Female Sexual Desire.
    Fantasia HC
    Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacodynamic effects of combined administration of flibanserin and alcohol.
    Stevens DM; Weems JM; Brown L; Barbour KA; Stahl SM
    J Clin Pharm Ther; 2017 Oct; 42(5):598-606. PubMed ID: 28608926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain neuronal activation induced by flibanserin treatment in female rats.
    Gelez H; Clement P; Compagnie S; Gorny D; Laurin M; Allers K; Sommer B; Giuliano F
    Psychopharmacology (Berl); 2013 Dec; 230(4):639-52. PubMed ID: 23857113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications.
    Kingsberg SA; McElroy SL; Clayton AH
    Sex Med Rev; 2019 Jul; 7(3):380-392. PubMed ID: 30803922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
    Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
    Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addendum: Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529137
    [No Abstract]   [Full Text] [Related]  

  • 36. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Sep; 57(1478):133-5. PubMed ID: 26375434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.